Lyndra Therapeutics

0 followers

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Industries

Employees

51-200

Links


Org chart

Colin Gardner
Co-Founder
Patrick Boen
Vice President Clinical Development
Michelle O'Connor
Associate Director, Analytical Research And Development
Jonathan Raber
Manufacture Engineer
Divya Krishnamurthy, Ph.D.
Senior Director, Workplace Operations And Safety
Kevin Scranton
Associate Clinical Data Scientist

Board & advisors

Amy Schulman
Executive Chair, Co-Founder
Zafrira Avnur
Board Member
Robert Langer
Co-Founder & Board Member
Giovanni Traverso
Co-Founder & Board Member
Douglas Dachille
Board Member
Jillian Moo-Young
Board Member
Kevin G. Guise
Board Member